September 2019 - The Biosphere

Biosphere tenant Iksuda Therapeutics presents first data on lead antibody drug conjugate, demonstrating effective tumour regression.

Archive

Biosphere tenant Iksuda Therapeutics presents first data on lead antibody drug conjugate, demonstrating effective tumour regression.

By The Biosphere|2022-02-18T10:20:26+00:00September 30th, 2019|Archive|

Iksuda Therapeutics (Iksuda), a developer of next generation Antibody Drug Conjugates (ADCs), today announced

Comments Off

Transformational cell technology helping to improve lives across the world

Archive

Transformational cell technology helping to improve lives across the world

By The Biosphere|2022-02-18T10:20:12+00:00September 5th, 2019|Archive|

Atelerix is a spin out from Newcastle University and pioneers in the storage and

Comments Off

Elmers Great North Parade comes to the Helix.

Archive

Elmers Great North Parade comes to the Helix.

By The Biosphere|2022-02-18T10:20:05+00:00September 5th, 2019|Archive|

On the 21st August we welcomed a new visitor to Newcastle Helix. Electric Ellie!

Comments Off

The Biosphere has been shortlisted for ‘Best Sector Support’ award in the OBN Awards 2019

Archive

The Biosphere has been shortlisted for ‘Best Sector Support’ award in the OBN Awards 2019

By The Biosphere|2022-02-18T10:19:56+00:00September 5th, 2019|Archive|

The Biosphere has been recognised for outstanding levels of support to companies in the

Comments Off

This Website is committed to ensuring digital accessibility for people with disabilitiesWe are continually improving the user experience for everyone, and applying the relevant accessibility standards.

Conformance status

Developed by AGHAI Web Development